Abstract Methicillin-resistant Staphylococcus aureus (MRSA) infection poses a severe threat to global public health due to its high mortality. Currently. polymyxins are mainly used for the treatment of Gram-negative bacterial-related infection. while exhibiting limited antibacterial activities against Staphylococcus aureus (S. https://www.markbroyard.com/